Jon Kayyem - GenMark Diagnostics Insider

GenMark Diagnostics Inc -- USA Stock  

USD 4.66  0.17  3.52%

Founder and Sr. VP of RandD

Dr. Jon Faiz Kayyem, Ph.D., is serving as Senior Vice President Research and Development of GenMark Diagnostics Inc. Jon Faiz Kayyem, Ph.D. has served as Senior Vice President, Research and Development since June 2013. Dr. Kayyem previously served as the Companys Chief Scientific Officer from August 2010 to June 2013. Dr. Kayyem served as President and Chief Executive Officer of the Company from May 2010 to August 2010. From August 2009 to May 2010, Dr. Kayyem served as President and Chief Executive Officer of Osmetech plc and Chairman of the board of directors of Osmetech plc from January 2009 to August 2009. Dr. Kayyem attended Yale University and received a combined M.S. and B.S. in Molecular Biophysics and Biochemistry in 1985. Dr. Kayyem received his Ph.D. in Molecular Biology in 1991 from The California Institute of Technology
Age: 52  Founder Since 2013  Ph.D    
Kayyem remained at Caltech as a Senior Research Fellow until 1995, when he founded Clinical Micro Sensors to commercialize technical innovations he developed while at Caltech. In 2000, Clinical Micro Sensors was sold to Motorola, Inc., and subsequently purchased by Osmetech plc in 2005. In 2004, Dr. Kayyem left Clinical Micro Sensors and cofounded the biotechnology fund management company, Efficacy Capital Limited, where he served as managing partner until September 2009.

Management Efficiency

The company has return on total asset (ROA) of (33.52) % which means that it has lost $33.52 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (93.54) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 29.47 M in liabilities with Debt to Equity (D/E) ratio of 36.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. GenMark Diagnostics Inc has Current Ratio of 2.91 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

GenMark Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, commercializes, sells, and supports instruments and molecular tests based on its proprietary eSensor detection technology. GenMark Diagnostics Inc (GNMK) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 233 people. GenMark Diagnostics is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Aroon Oscillator Now

Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Hide  View All  NextLaunch Aroon Oscillator
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add GenMark Diagnostics Inc to your portfolio

Top Management

GenMark Diagnostics Inc Leadership Team
James McNally, President, MBA
Michael Gleeson, SVP
Kevin OBoyle, Director
Jennifer Williams, SVP
Scott Mendel, CFO, MBA
Ingo Chakravarty, SVP
James Fox, Director
Jon Kayyem, Founder, Ph.D
Eric Stier, President
Jeffrey Hawkins, SVP
Michael Kagnoff, Director
Hany Massarany, CEO, MBA
Lisa Giles, Director
Daryl Faulkner, Director

Stock Performance

GenMark Diagnostics Performance Indicators